Alpha Tau Medical (DRTS) Interest Expenses (2020 - 2025)

Alpha Tau Medical (DRTS) has 6 years of Interest Expenses data on file, last reported at $22.6 million in Q4 2025.

• For the quarter ending Q4 2025, Interest Expenses rose 217.17% year-over-year to $22.6 million; the trailing twelve-month figure through Dec 2025 stood at $22.6 million (up 217.17% YoY), and the FY2025 full-year result was $22.6 million, up 137.51% from the prior year.
• Interest Expenses improved to $22.6 million in Q4 2025, from $7.1 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $22.6 million in Q4 2025 to a low of $4000.0 in Q1 2021.
• A 5-year average of $5.6 million and a median of $4.4 million in 2021 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses surged 800.0% in 2022 and climbed 14.81% in 2023, its largest moves.
• Tracing DRTS's Interest Expenses over 5 years: stood at $3.8 million in 2021, then surged by 33.68% to $5.1 million in 2022, then grew by 14.81% to $5.8 million in 2023, then grew by 22.24% to $7.1 million in 2024, then surged by 217.17% to $22.6 million in 2025.
• Business Quant data shows DRTS's Interest Expenses at $22.6 million in Q4 2025, $7.1 million in Q4 2024, and $5.8 million in Q4 2023.